ES2036809T3 - Variantes de la hirudina, sus utilizaciones y los procedimientos para obtenerlas. - Google Patents

Variantes de la hirudina, sus utilizaciones y los procedimientos para obtenerlas.

Info

Publication number
ES2036809T3
ES2036809T3 ES198989400621T ES89400621T ES2036809T3 ES 2036809 T3 ES2036809 T3 ES 2036809T3 ES 198989400621 T ES198989400621 T ES 198989400621T ES 89400621 T ES89400621 T ES 89400621T ES 2036809 T3 ES2036809 T3 ES 2036809T3
Authority
ES
Spain
Prior art keywords
hirudine
variants
procedures
improve
order
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198989400621T
Other languages
English (en)
Spanish (es)
Inventor
Michael Courtney
Eric Degryse
Gerard Loison
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transgene SA
Original Assignee
Transgene SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene SA filed Critical Transgene SA
Application granted granted Critical
Publication of ES2036809T3 publication Critical patent/ES2036809T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Removal Of Specific Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
ES198989400621T 1988-03-08 1989-03-06 Variantes de la hirudina, sus utilizaciones y los procedimientos para obtenerlas. Expired - Lifetime ES2036809T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8802925A FR2628429B1 (fr) 1988-03-08 1988-03-08 Variants de l'hirudine, leurs utilisations et les procedes pour les obtenir

Publications (1)

Publication Number Publication Date
ES2036809T3 true ES2036809T3 (es) 1993-06-01

Family

ID=9364012

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198989400621T Expired - Lifetime ES2036809T3 (es) 1988-03-08 1989-03-06 Variantes de la hirudina, sus utilizaciones y los procedimientos para obtenerlas.

Country Status (10)

Country Link
US (1) US5087613A (enExample)
EP (1) EP0332523B1 (enExample)
JP (1) JP2961118B2 (enExample)
AT (1) ATE84571T1 (enExample)
CA (1) CA1341429C (enExample)
DE (1) DE68904330T2 (enExample)
ES (1) ES2036809T3 (enExample)
FR (1) FR2628429B1 (enExample)
GR (1) GR3007254T3 (enExample)
PT (1) PT89923B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8907110D0 (en) * 1988-05-04 1989-05-10 Ciba Geigy Ag Improvements in the production of polypeptides
US5268296A (en) * 1988-06-11 1993-12-07 Ciba-Geigy Corporation DNA vector and recombinant host cell for production of hirullin P6 and P18
DE3835815A1 (de) * 1988-10-21 1990-04-26 Hoechst Ag Neue isohirudine
FR2646437B1 (fr) * 1989-04-28 1991-08-30 Transgene Sa Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
US5663141A (en) * 1989-12-01 1997-09-02 Basf Aktiengesellschaft Hirudin/polyalkylene glycol conjugates and hirudin muteins
US5780303A (en) * 1990-04-06 1998-07-14 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US6521594B1 (en) 1990-04-06 2003-02-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5612311A (en) * 1990-04-06 1997-03-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5672585A (en) * 1990-04-06 1997-09-30 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
JP3111075B2 (ja) * 1990-07-24 2000-11-20 メレルダウファーマスーティカルズ インコーポレイテッド 抗凝固ペプチド
US5574012A (en) * 1990-07-24 1996-11-12 Merrell Pharmaceuticals Inc. Analogs of hirudin having anti-platelet activity
AU640502B2 (en) * 1990-07-24 1993-08-26 Merrell Dow Pharmaceuticals Inc. Analogs of hirudin having antiplatelet activity
GB9023149D0 (en) * 1990-10-24 1990-12-05 British Bio Technology Proteins and nucleic acids
US5837808A (en) * 1991-08-20 1998-11-17 Baxter International Inc. Analogs of hirudin
WO1993004082A1 (en) * 1991-08-20 1993-03-04 Baxter International Inc. Analogs of hirudin
GB9209032D0 (en) * 1992-04-25 1992-06-10 Ciba Geigy Ag New peptide derivatives
NZ268159A (en) * 1993-06-11 1997-03-24 Merrell Pharma Inc Anticoagulant and antiplatelet peptides and their use
DE4404168A1 (de) * 1994-02-10 1995-08-17 Hoechst Ag Hirudinderivate und Verfahren zu deren Herstellung
US8377863B2 (en) * 2007-05-29 2013-02-19 Unigene Laboratories Inc. Peptide pharmaceutical for oral delivery
CA2973099C (en) 2015-01-12 2021-09-14 Enteris Biopharma, Inc. Solid oral dosage forms

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3586333T2 (de) * 1984-03-27 1992-12-10 Transgene Sa Expressionsvektoren fuer hirudin, transformierte zellen und verfahren zur herstellung von hirudin.
DE3429430A1 (de) * 1984-08-10 1986-02-20 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens
FR2607517B2 (fr) 1986-12-01 1989-12-22 Transgene Sa Vecteurs d'expression de variants de l'hirudine dans les levures, procede et produit obtenu

Also Published As

Publication number Publication date
DE68904330T2 (de) 1993-05-19
PT89923B (pt) 1994-05-31
EP0332523B1 (fr) 1993-01-13
GR3007254T3 (enExample) 1993-07-30
ATE84571T1 (de) 1993-01-15
EP0332523A1 (fr) 1989-09-13
US5087613A (en) 1992-02-11
CA1341429C (fr) 2003-05-27
PT89923A (pt) 1989-11-10
FR2628429B1 (fr) 1990-12-28
JPH029390A (ja) 1990-01-12
FR2628429A1 (fr) 1989-09-15
JP2961118B2 (ja) 1999-10-12
DE68904330D1 (de) 1993-02-25

Similar Documents

Publication Publication Date Title
NL980031I1 (nl) Fenylcarbamaten.
SE8501709D0 (sv) Improvements in or relating to intrleukin therapy
ES2024462B3 (es) Terpolimeros su aplicacion en acondicionadores para el cabello y acondicionadores que los contienen.
IT1126452B (it) Testa di estrusione per profilati per infissi e simili,nonche' profilato ottenuto
MX9100032A (es) Procedimiento para preparar fenoxialquilisoxazoles y furanos substituidos heterociclicos.
IT1209603B (it) Derivati 2,6-disostituiti di naftalene, procedimento per prepararli e loro uso nel campo farmaceutico e cosmetico.
IT1003526B (it) Dispositivo per la produzione continua di pannelli di trucioli o simili
IT1203738B (it) Bilirubin-cssidasi termostabile e procedimento per produrla
IT1102483B (it) Struttura per contrassegni di segnalazione insegne e simili
ES2193248T3 (es) Antraquinonas mono- y disulfosustituidas y su uso para el tratamiento de desordenes de la matriz osea.
RO72151A (ro) Explozivi sub forma de gel spumati,stabilizati
FI854074L (fi) Peptid-substituerade heterocykliska immunostimulanter.
MX161742A (es) Mejoras en aparato para probar el funcionamiento del higado
IT1190143B (it) Eteri 5,6-epossi-7-ossabicicloeptano sostituiti utili nel trattamento di trombosi
ES554843A0 (es) Procedimiento selectivo para la preparacion del isosorbido-5-mononitrato
IT1188704B (it) Derivati insaturi cicloalifatici,loro procedimenti di prepatazione e loro impiego in terapia e in cosmetica
ATE112269T1 (de) Monohydrochlorid und monomethansulfonat von amonafide.
IT1000301B (it) Perfezionamento negli accendisi gari e simili
TR22461A (tr) Aluminyum fosfinat-amin katilma ueruenleri,ve bunlarin ueretimi ve kullanimi
ES2037657T3 (es) 4-tienil-dihidropiridinas, procedimiento para su preparacion y su aplicacion en medicamentos.
ES552259A0 (es) Perfeccionamientos en la fabricacion de soportes para mechas de velas y similares.
IT1221466B (it) Serie completa di dilatatori uterini
ES555550A0 (es) Dispositivo para aumentar el tiempo de utilizacion de una fuente de luz electroluminiscente
IT979551B (it) Dispositivo per la protezione della faccia nella guida di vei coli in lavori specializzati e simili
ES543760A0 (es) Procedimiento para reducir el efecto gel en la obtencion de polimeros acrilicos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 332523

Country of ref document: ES